Research Training In Gastroenterology
胃肠病学研究培训
基本信息
- 批准号:9068930
- 负责人:
- 金额:$ 33.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): This renewal application for T32 DK067872, Research Training in Gastroenterology, at the University of Maryland, Baltimore (UMB) requests five years of support for four predoctoral and five postdoctoral (MD, PhD, MD/PhD) trainees. Program goals are unchanged: to seek and prepare talented trainees for academic careers in gastroenterology by offering an integrated, interdisciplinary curriculum that emphasizes mucosal biology & immunology, cell signaling & proliferation, enteric pathogens & vaccine development, and clinical research. UMB entities represented by faculty mentors with strong NIH support cut across schools and departments to include the Schools of Medicine (Departments of Medicine, Pediatrics, Surgery, Epidemiology & Public Health, Microbiology & Immunology, Biochemistry & Molecular Biology) and Pharmacy (Department of Pharmaceutical Sciences). Broad-based training opportunities allow predoctoral trainees to obtain PhD or MD/PhD degrees and postdoctoral trainees to earn MS, MPH or PhD degrees. Under the supervision of expert mentors, the training program is designed to enable trainees to develop hypotheses, design and perform basic or clinical research to test these hypotheses, become expert in at least one substantive area relevant to digestive diseases, develop skills needed for oral and written presentations, master the principles of responsible conduct of research, and prepare for transition to an academic career in digestive diseases. Three research tracks (Mucosal Immunology & Inflammation; Epithelial Cell Biology & Signaling; Clinical & Translational Science) are directed by accomplished senior investigators and comprised of highly productive experienced mentors who interact both within and amongst these tracks. Since its inception in 2005, this T32 program has been highly successful; all training slots were filled, trainee retention was 100%, and productivity was outstanding. All six predoctoral trainees who completed training qualified for the PhD degree. In the current funding period, eight of 12 postdoctoral trainees (66%) either received or are poised to receive advanced degrees (MS, MPH or PhD). This T32 program remains extraordinarily diverse; since its inception we trained 33 persons of whom 19 (58%) are women and 6 (18%) are underrepresented minorities. Of 16 postdoctoral trainees who completed all training, 13 (81%) have academic faculty appointments and two successfully competed for NIH funding (NIDDK K08 awards). During the current funding cycle, the program has continued to mature and grow by adding funded, productive faculty with strong mentoring credentials, and by innovation (e.g. leveraging the ABIM research pathway to identify and recruit promising medical students for mentored T32-sponsored pathways leading to academic gastroenterology, adding novel self-assessment tools, and enhancing instruction in Responsible Conduct of Research with our own series of T32 faculty-led seminars that address specific ethical issues). We also provide evidence that this T32 program adds great value to the UMB scientific community by attracting investigators from other disciplines to digestive disease-related research.
描述(由申请人提供):此 T32 DK067872 胃肠病学研究培训续签申请,位于巴尔的摩马里兰大学 (UMB),要求为四名博士前和五名博士后(MD、PhD、MD/PhD)学员提供五年的支持项目目标不变:通过提供强调粘膜生物学和免疫学、细胞信号传导和UMB 实体以教师导师为代表,并得到 NIH 的大力支持,跨学院和院系,包括医学院(医学系、儿科、外科、流行病学和公共卫生、微生物学和免疫学系)。 、生物化学与分子生物学)和药学(药物科学系)提供广泛的培训机会,使博士前学员能够获得博士学位或医学博士/博士学位,博士后学员也能够获得学位。在专家导师的指导下,培训计划旨在使学员能够提出假设,设计并进行基础或临床研究来检验这些假设,成为至少一个与消化疾病相关的实质性领域的专家。 ,培养口头和书面演示所需的技能,掌握负责任的研究原则,并为过渡到消化疾病的学术生涯做好准备(粘膜免疫学与炎症;上皮细胞生物学与信号转导;临床)。和转化科学)由经验丰富的高级研究人员指导,并由富有成效的、经验丰富的导师组成,自 2005 年启动以来,该 T32 计划非常成功,所有培训名额均已满,学员保留率达到 100 人。 %,并且完成培训的所有 6 名博士前学员均获得博士学位。在当前资助期内,12 名博士后学员中的 8 名(66%)已获得或即将获得高级学位。 (硕士、公共卫生硕士或博士)。自启动以来,我们培训了 33 名博士后学员,其中 19 名(58%)是女性,6 名(18%)是少数族裔。 13 名 (81%) 拥有学术教职人员任命,其中两名成功获得 NIH 资助(NIDDK K08 奖项)。在当前的资助周期中,该项目通过增加资金不断成熟和发展。资金雄厚、富有成效的教师队伍,具有强大的指导资质,并通过创新(例如,利用 ABIM 研究途径来识别和招募有前途的医学生,以接受 T32 资助的学术胃肠病学指导途径,添加新颖的自我评估工具,并加强负责任行为方面的指导我们还提供证据表明,该 T32 计划通过吸引其他学科的研究人员参与,为 UMB 科学界增添了巨大价值)。消化系统疾病相关研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEAN-PIERRE RAUFMAN其他文献
JEAN-PIERRE RAUFMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEAN-PIERRE RAUFMAN', 18)}}的其他基金
Muscarinic Receptors Regulate Colon Cancer Stem Cell Function and Invasiveness
毒蕈碱受体调节结肠癌干细胞功能和侵袭性
- 批准号:
10413032 - 财政年份:2021
- 资助金额:
$ 33.75万 - 项目类别:
Muscarinic Receptors Regulate Colon Cancer Stem Cell Function and Invasiveness
毒蕈碱受体调节结肠癌干细胞功能和侵袭性
- 批准号:
10664886 - 财政年份:2021
- 资助金额:
$ 33.75万 - 项目类别:
Muscarinic Receptors Regulate Colon Cancer Stem Cell Function and Invasiveness
毒蕈碱受体调节结肠癌干细胞功能和侵袭性
- 批准号:
10260301 - 财政年份:2021
- 资助金额:
$ 33.75万 - 项目类别:
Role of M3 muscarinic receptors in bile acid-induced colon cancer
M3毒蕈碱受体在胆汁酸诱导的结肠癌中的作用
- 批准号:
7516673 - 财政年份:2008
- 资助金额:
$ 33.75万 - 项目类别:
Role of M3 muscarinic receptors in bile acid-induced colon cancer
M3毒蕈碱受体在胆汁酸诱导的结肠癌中的作用
- 批准号:
7683927 - 财政年份:2008
- 资助金额:
$ 33.75万 - 项目类别:
Role of M3 muscarinic receptors in bile acid-induced colon cancer
M3毒蕈碱受体在胆汁酸诱导的结肠癌中的作用
- 批准号:
8114173 - 财政年份:2008
- 资助金额:
$ 33.75万 - 项目类别:
Role of M3 muscarinic receptors in bile acid-induced colon cancer
M3毒蕈碱受体在胆汁酸诱导的结肠癌中的作用
- 批准号:
7888241 - 财政年份:2008
- 资助金额:
$ 33.75万 - 项目类别:
Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学研究培训
- 批准号:
10397620 - 财政年份:2005
- 资助金额:
$ 33.75万 - 项目类别:
相似国自然基金
基于“数智情绪滋养”视角的延展实境应急培训系统涵义游戏化交互设计理论与实证研究
- 批准号:72371064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
新型矿物能源转换与多能利用基础研究短期人才培训
- 批准号:52342401
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:专项基金项目
会议培训类:“亚洲生态环境保护:古记录研究的机遇与挑战”国际会议
- 批准号:
- 批准年份:2022
- 资助金额:9 万元
- 项目类别:
基于计划行为理论公众实施心肺复苏的行为机制及急救培训策略研究
- 批准号:82160647
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
会议培训类 –生活源排放的环境行为和效应研究培训
- 批准号:
- 批准年份:2021
- 资助金额:9 万元
- 项目类别:
相似海外基金
Enhancing Mentoring of Diverse Early Career Researchers
加强对多元化早期职业研究人员的指导
- 批准号:
10797836 - 财政年份:2023
- 资助金额:
$ 33.75万 - 项目类别:
Sleep-Wake Cycles of Individuals with Inflammatory Bowel Disease
炎症性肠病患者的睡眠-觉醒周期
- 批准号:
10604701 - 财政年份:2023
- 资助金额:
$ 33.75万 - 项目类别:
Anticoagulant use, safety, and effectiveness for venous thromboembolism prevention in inflammatory bowel disease patients
炎症性肠病患者预防静脉血栓栓塞的抗凝剂使用、安全性和有效性
- 批准号:
10887842 - 财政年份:2023
- 资助金额:
$ 33.75万 - 项目类别:
Disrupted sleep architecture in adolescents with functional abdominal pain disorders
患有功能性腹痛疾病的青少年的睡眠结构被破坏
- 批准号:
10641146 - 财政年份:2023
- 资助金额:
$ 33.75万 - 项目类别:
Defining Small Intestinal Microbial Landscapes To Improve Therapeutics For Gastrointestinal Disease
定义小肠微生物景观以改善胃肠道疾病的治疗
- 批准号:
10571946 - 财政年份:2023
- 资助金额:
$ 33.75万 - 项目类别: